NEFL and myeloid sarcoma: In MS, blood-based serum neurofilament light chain (sNfL), a neuron-specific cytoskeletal protein, was found elevated in specimens of patients even 6 years (4–10-year range) before the onset of clinical manifestations of disease (Bjornevik et al., 2020).